BIONNALE 2015

 

Agenda_Bionnale2015

 

DETAILED SCHEDULE

 

BIONNALE Agenda I

Hot topics in the cluster (drug development, glycobiotech, regmed, diagnostics)

In “Hot topics in the cluster” we bring you the latest topics in biotechnology and the pharmaceuticals industry in Berlin and Brandenburg. Experts from academia and industry illuminate their respective topics and look at them from a bird's eye view, delving into the questions of where, how and with whom cooperation in the region could be particularly riveting. Furthermore, examples of successful projects show in which dimensions research and development is happening in the region.

Moderation: Dr. Holger Eickhoff, Scienion AG, Berlin

13:00-13:30
New developments in Drug Development
Dr. Matthias Gottwald, Bayer AG, Berlin

13:30-14:00
New developments in Glycobiology
Dr. Stefan Kubick, Fraunhofer IZI, Potsdam-Golm

14:00-14:30
New developments in Regenerative Medicine
Prof. Dr. Carsten Tschöpe, BCRT, Berlin

14:30-15:00
New developments in Diagnostics
Prof. Dr. Dirk Roggenbuck, Medipan GmbH, Dahlewitz

 

BIONNALE Agenda II

“No IP – no money? (Big) Data in clinical development“

At present, stakeholders involved in drug development experience a significant shift regarding data transparency. While in the past the focus of transparency was on safety reporting, efficacy as well as study results reporting will come on top in the near future. The European Medicines Agency just published its final policy on this issue. In the session “No IP – no money? (Big) Data in clinical development“ the basic principles will be outlined as well as the consequences on several levels including the crucial question whether this amount of transparency poses a potential risk for IP protection especially for small- and medium-sized biotech companies.

Moderation: Dr. Sabine Sydow, Head of vfa bio

15:30-15:40
Welcome
Dr. Sabine Sydow, Head of vfa bio, Berlin

15:40-15:55
Transparency of clinical data: What is it all about?
Dr. Claus Göbel, Head of Clinical Operations Deutschland, Roche Pharma, Grenzach-Wyhlen

16:00-16:15
Aim and benefit: All trials registered - all results reported
Prof. Dr. Gerd Antes, Director, German Cochrane Centre, Freiburg

16:20-16:35
Clinical trials transparency and patient communication
Dr. Holger Maria Rohde, Director, Strategy Implementation Lead, Merck Serono, Darmstadt

16:40-16:55
„Big data“ and its impact on transparency
Thomas Klein, CEO, Cytolon, Berlin

17:00-17:15
Patent lawyer’s perspective: Is transparency a risk for our IP?
Dr. Ute Kilger, Patent Attorney, Boehmert & Boehmert, Berlin

17:00-17:30
Questions? Answers!

 

BIONNALE Session: Industrial Biotech

Like in both previous years, a thematic session is dedicated to the specific field of Industrial Biotechnology. It will focus this year on two main topics: the role of enzyme technologies for bio-based industries and the competitiveness challenge for bio-based products. Join and get an insight into promising technologies to meet the challenges for successful bio-based products!

13:00-13:15
Welcome
Dr. Joachim Venus, Leibniz-Institut für Agrartechnik Potsdam-Bornim e.V. (ATB)

Paving the way for the bio-based industries with enzymes

Moderation: Prof. Dr. Katrin Scheibner, BTU Senftenberg

13:20-13:45
Enzymes for application in pharmaceutical research
Prof. Dr. Martin Hofrichter, TU Dresden, Dresden

13:45-14:10
Enzymatic degradation of plant biomass
Dr. Stefan Kühnel, Biopract GmbH, Berlin

14:10-14:35
Enzymes for biogas plant
Dr. Matthias Plöchl, im Namen des Leibniz Instituts ATB, Potsdam

14:35-15:00
Discussion

15:00-15:30
Coffee Break

Innovative approaches for competitive bio-based processing

Moderation: Dr. Joachim Venus, Leibniz-Institut für Agrartechnik Potsdam-Bornim e.V. (ATB), Potsdam

15:35-16:00
Economic lignocellulose pretreatment for microbial processing: the LX-Process
Dr. Friedrich Streffer, maxbiogas GmbH, Marienwerder

16:00-16:25
Innovative Technology for High Value Compounds Production
Ivaylo Georgiev, CCO, Phytowelt GreenTechnologies GmbH, Nettetal

16:25-16:50
Robot based bioprocess development for the chemo-enzymatic synthesis of nucleoside analogues
Prof. Dr. Peter Neubauer, TU Berlin, Berlin
Dr. Anke Wagner, BioNukleo UG, Berlin

16:50-17:15
Optimisation of bio-based processing
Dr. Jörg Riesmeier, Direvo Industrial Biotechnology GmbH, Cologne

17:15-17:30
Closing remarks
Dr. Joachim Venus, Leibniz-Institut für Agrartechnik Potsdam-Bornim e.V. (ATB), Potsdam

 

Cooperation Track

Companies, universities and research institutions are invited to apply for a short presentation (10 minutes) on their competences. During the whole afternoon you can listen to short talks on various topics. From strategic partnerships, to process improvement, to co-development – talk about your expertise and share your needs when it comes to developing your research or product further.

You can find the final schedule of the Cooperation Track here.

 

Matchmaking Meetings

The organized matchmaking helps you to identify new contacts in the Berlin-Brandenburg region and beneath the international attendees of the Bionnale. You can search for potential partners via the web based matchmaking tool. Short meetings of 15 minutes are scheduled automatically to the participant’s convenience. It is possible to accept or decline requests from others. Your meeting schedule will be based on your accepted requests.

 

BIONNALE Evening Reception starting at 18.00 h

The evening event with a reception is the highlight of the BIONNALE, bringing you words of welcome from politics, interesting short lectures and a thrilling finale in the BIONNALE Speed Lecture Award.

We then invite you to an evening of socializing afterwards.

Moderation: Dr. Kai Uwe Bindseil, Head of Division and Cluster Manager, Life Sciences I Healthcare Industries, Berlin

18:00-19:30
Welcome
Dr. Kai Uwe Bindseil, Head of Division and Cluster Manager, Life Sciences I Healthcare Industries, Berlin
Prof. Dr. Detlev Ganten, Chairman of the Board of Trustees, Stiftung Charité, Berlin

Keynote: Pfizer Research and Development in Germany – our vision for 2020
Peter Albiez, Pfizer Global Innovative Pharma Lead & Country Manager Germany, Pfizer Deutschland GmbH, Berlin

Finale of the BIONNALE Speed Lecture Award
Presentation: Prof. Dr. Tilman Grune, Scientific Director, German Institute of Human Nutrition (DIfE), Nuthetal

Music

Keynote: New models to Identify and Nurture Healthcare Innovation
Dr. Kurt Hertogs, Platform Innovation & Incubator Strategy Leader, Johnson & Johnson Innovation, London

Closing Remarks and Award Ceremony of the BIONNALE Speed Lecture Award
Dr. Kai Uwe Bindseil, Head of Division and Cluster Manager, Life Sciences I Healthcare Industries, Berlin

19:30
Get Together

 

Charité Entrepreneurship Summit

For the first time, this year's BIONNALE will be held in cooperation with the Charité Entrepreneurship Summit, where over 400 entrepreneurs, clinicians, top-notch researchers, investors, legal experts, and senior executives in the healthcare industry will once again meet to discuss the newest medical innovations and the future of healthcare. Do not miss the exciting opportunities of this event and mark the 28th and 29th of May in your calendar!

Separate registration required.

 

You can find the Agenda as a downloadeable pdf file here.

Registration
closed since 25 May 2015
Organisers
Schedule
Registration 1 Feb – 25 May
Meeting Selection 4 May – 25 May
Event 27 May
Details
Language English
Costs Free of charge
Venue Berlin, Ludwig-Erhard-Haus
Bilateral Meetings
Participants 200
Meetings 203
Participants
Austria 1
China 1
Denmark 2
Estonia 1
France 5
Germany 634
Italy 2
Japan 2
Others 2
Poland 34
Portugal 1
South Korea 4
Spain 1
Switzerland 4
United Kingdom 13
USA 8
Total 715
Profile Views
Before Event10963
After Event 10405
Total21368